This month marked the start of the country’s first legal growing season for cannabis.
In May 2023, the Moroccan government allowed farmers to begin cultivation of cannabis for the legal market, two years after allowing farming for medical, industrial, and export purposes (1,2). The move was also intended to help impoverished farmers in the region and curb the influence of the illegal market (1).
Cannabis is mostly grown in the northern mountainous region and the country is considered by the United Nations (UN) to be the world's largest producer of cannabis resin (2). Cannabis for recreational purposes is still illegal and growing it has been illegal since 1976 (1).
"The legal market will guarantee them income four to five times higher than what they earned illegally," said Mohammed El Guerrouj, director of Agence Nationale de Réglementation des Activités Relatives au Cannabis (ANRAC) (2). "Through their cooperatives, they will negotiate prices. They will have a fixed income, which will provide them with the ability to invest and improve their lifestyle."
Cannabis has been grown illegally in the country for decades, but last year the first 10 permits were given to grow cannabis for the legal market (3). The first permit for a cannabis laboratory to process cannabis in food and pharmaceutical industries was issued last year as well (4).
“More than 400 farmers have already obtained a cultivation permit and 75 operators have received processing, marketing or export permits, including pharmaceutical industries, agribusinesses, cooperatives and individuals," El Guerroj also stated. (2). The Moroccan government distributed seeds manufactured in Switzerland to the participating farmers to begin the cultivation (1).
Concerns for the future direction and impact of the market include resistance from the farmers who are most familiar with the illegal market and the lack of plans to legalize cannabis for recreational use (2).
References
New Study Finds Cannabinoids May Offer A Safer Pain Relief Option Without Addiction Risks
January 31st 2025Yale researchers investigated in a recent study how cannabinoids can be used as an alternative chronic pain treatment without addiction risks and found that they can help lower pain signals in Nav1.8.
Ep 24, Part III: Data Transparency in Cannabis Testing with Yasha Kahn
December 26th 2024In the final part of this episode, Evan Friedmann and Yasha Kahn discuss the need for a national entity to centralize cannabis data collection, moving from snapshot data to continuous updates. They emphasize the importance of accurate lab data and adverse event tracking, suggesting QR codes on packaging to report issues. Yasha suggests harsher consequences for result manipulation and suggests collaboration between state departments and federal entities to support underfunded regulators. They also discuss the potential benefits of off-the-shelf testing and the importance of stability testing. Finally, Yasha shares his top three reading recommendations for the audience.
Ep 24, Part II: Data Transparency in Cannabis Testing with Yasha Kahn
December 12th 2024Evan Friedmann and Yasha Kahn, co-founder of MCR Labs, discuss the discrepancies between current regulations and data on mycotoxins and pesticides in cannabis products. They highlight the need for updated regulations based on new data, emphasizing the importance of accurate testing and labeling. They also discuss the issue of result manipulation, particularly in THC content, and the need for public health officials to address this. Yasha suggests making testing data public to enhance oversight and suggests a national entity to manage this data for better consistency and public safety.